BioRestorative Therapies Inc Sustainability Reports
BioRestorative Therapies, Inc. develops therapeutic products and cellular therapies using cell and tissue protocols, primarily involving adult stem cells. Its clinical programs focus on treating degenerative disc disease and metabolic disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300I1PJXVT7ISIV91
FIGI: BBG001S90FP6
5 reports from 2012 to 2024
